Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanlong Lin

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Drug Investigation|November 23, 2023
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance StudyWei Zhuang, Mei Lu, Ye Wu, et al.
Pediatrics and Neonatology|February 22, 2022
Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical recordsQuanyao Chen, Jun Wan, Wei Shen, et al.
British Journal of Clinical Pharmacology|May 12, 2023
Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemWei Zhuang, Jiabing Xu, Ye Wu, et al.
Expert Opinion on Drug Safety|July 2, 2025
Evaluating safety risks of ischaemic colitis with taxanes: a disproportionality analysis based on FDA adverse event Reporting systemYufang Liao, Yanbin Zeng, Xiaorong Su, et al.
Frontiers in Neuroscience|September 1, 2023
The assessment of interhemispheric imbalance using functional near-infrared spectroscopic and transcranial magnetic stimulation for predicting motor outcome after strokeSongmei Chen, Xiaolin Zhang, Xixi Chen, et al.
Frontiers in Neurology|June 5, 2023
Case report: High-frequency repetitive transcranial magnetic stimulation for treatment of hereditary spastic paraplegia type 11Songmei Chen, Zhiqing Zhou, Meng Ren, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Drug Investigation|November 23, 2023
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance StudyWei Zhuang, Mei Lu, Ye Wu, et al.
Pediatrics and Neonatology|February 22, 2022
Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical recordsQuanyao Chen, Jun Wan, Wei Shen, et al.
British Journal of Clinical Pharmacology|May 12, 2023
Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemWei Zhuang, Jiabing Xu, Ye Wu, et al.
Expert Opinion on Drug Safety|July 2, 2025
Evaluating safety risks of ischaemic colitis with taxanes: a disproportionality analysis based on FDA adverse event Reporting systemYufang Liao, Yanbin Zeng, Xiaorong Su, et al.
Frontiers in Neuroscience|September 1, 2023
The assessment of interhemispheric imbalance using functional near-infrared spectroscopic and transcranial magnetic stimulation for predicting motor outcome after strokeSongmei Chen, Xiaolin Zhang, Xixi Chen, et al.
Frontiers in Neurology|June 5, 2023
Case report: High-frequency repetitive transcranial magnetic stimulation for treatment of hereditary spastic paraplegia type 11Songmei Chen, Zhiqing Zhou, Meng Ren, et al.
Pageof 3